Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FibroBiologics, Inc.FBLG · Entity 7875 | Director | June 23, 2026 | June 24, 2026 |
| NUVASIVE INCNUVA · Entity 110002 | President | June 08, 2020 | June 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FibroBiologics, Inc.
Report date June 23, 2026 · Filed June 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2036-06-22 | Direct | 30,803 |
Reported balance
After 2026-06-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 30,803 · Balance 30,803 F1: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.
NUVASIVE INC
Report date June 08, 2020 · Filed June 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 82,595 |
Reported balance
After 2020-06-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-06-08 · Sale · Disposed 3,000 · Balance 82,595 F1: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Amount includes 354 shares acquired under the Issuer's employee stock purchase plan in April 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
F2: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Amount includes 354 shares acquired under the Issuer's employee stock purchase plan in April 2020.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Sight Sciences, Inc.
Report date August 31, 2025 · Filed September 03, 2025
Section 16 reporting ended · disclosed 2025-09-03. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 27, 2017 Filed Dec 29, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 5,325 | $58.84 | $313,323.00 |
DisclosureSEC source: 0001209191-17-067668 · doc4.xml · nonDerivative · entry 3 Link Matthew · CIK 0001565950 · EVP, Strategy, Tech & Corp Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,510 F2 · shares: Payment of exercise price and tax liability, as applicable, by Issuer's withholding of shares incident to the respective option exercise. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 429 shares acquired under the Issuer's employee stock purchase plan in April 2017. Read SEC document |
| December 27, 2017 Filed Dec 29, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 7,500 | $38.78 | $290,850.00 |
DisclosureSEC source: 0001209191-17-067668 · doc4.xml · nonDerivative · entry 2 Link Matthew · CIK 0001565950 · EVP, Strategy, Tech & Corp Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 429 shares acquired under the Issuer's employee stock purchase plan in April 2017. Read SEC document |
| December 26, 2017 Filed Dec 29, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | GiftCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067668 · doc4.xml · nonDerivative · entry 1 Link Matthew · CIK 0001565950 · EVP, Strategy, Tech & Corp Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,335 F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 429 shares acquired under the Issuer's employee stock purchase plan in April 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017911 · doc4.xml · derivative · entry 3 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on July 1, 2013. In accordance with the terms of the RSU award, the award vested as to 1,250 shares on March 1, 2014, March 1, 2015, March 1, 2016 and March 1, 2017. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on July 1, 2013. In accordance with the terms of the RSU award, the award vested as to 1,250 shares on March 1, 2014, March 1, 2015, March 1, 2016 and March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 652 | $75.68 | $49,343.36 |
DisclosureSEC source: 0001209191-17-017911 · doc4.xml · nonDerivative · entry 2 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,415 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017911 · doc4.xml · nonDerivative · entry 1 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 17:51 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 14,403 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009686 · doc4.xml · derivative · entry 1 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,403 Underlying: Common Stock · 14,403 shares Expires not disclosed F1 · security: Each performance restricted stock unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. On February 8, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the PRSU award's performance condition had been satisfied. In accordance with the terms of the PRSU award, the award will vest in full on March 1, 2019. As the PRSU award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. On February 8, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the PRSU award's performance condition had been satisfied. In accordance with the terms of the PRSU award, the award will vest in full on March 1, 2019. As the PRSU award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 2,660 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · derivative · entry 7 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,320 Underlying: Common Stock · 2,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on February 17, 2015. In accordance with the terms of the PRSU award, the award vested as to 2,661 shares on February 1, 2016, vested as to 2,660 shares on February 1, 2017, and will vest as to 2,660 shares on each of February 1, 2018 and February 1, 2019. F7 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on February 17, 2015. In accordance with the terms of the PRSU award, the award vested as to 2,661 shares on February 1, 2016, vested as to 2,660 shares on February 1, 2017, and will vest as to 2,660 shares on each of February 1, 2018 and February 1, 2019. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 11,602 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · derivative · entry 6 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,602 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on February 19, 2014. In accordance with the terms of the PRSU award, the award vested as to 11,602 shares on February 1, 2016 and February 1, 2017. F6 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on February 19, 2014. In accordance with the terms of the PRSU award, the award vested as to 11,602 shares on February 1, 2016 and February 1, 2017. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 4,122 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · derivative · entry 5 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,122 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on February 19, 2014. In accordance with the terms of the RSU award, the award vested as to 4,123 shares on February 1, 2015, and vested as to 4,122 shares on February 1, 2016 and February 1, 2017. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on February 19, 2014. In accordance with the terms of the RSU award, the award vested as to 4,123 shares on February 1, 2015, and vested as to 4,122 shares on February 1, 2016 and February 1, 2017. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 9,381 | $70.76 | $663,799.56 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · nonDerivative · entry 4 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,817 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 2,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · nonDerivative · entry 3 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 11,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · nonDerivative · entry 2 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 4,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007784 · doc4.xml · nonDerivative · entry 1 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 12,936 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001309 · doc4.xml · derivative · entry 4 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on January 1, 2013. In accordance with the terms of the RSU award, the award vested as to 12,937 shares on each of January 1, 2014 and January 1, 2015, and vested as to 12,936 shares on each of January 1, 2016 and January 1, 2017. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on January 1, 2013. In accordance with the terms of the RSU award, the award vested as to 12,937 shares on each of January 1, 2014 and January 1, 2015, and vested as to 12,936 shares on each of January 1, 2016 and January 1, 2017. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 7,970 | $67.36 | $536,859.20 |
DisclosureSEC source: 0001209191-17-001309 · doc4.xml · nonDerivative · entry 3 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,814 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 12,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001309 · doc4.xml · nonDerivative · entry 2 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| December 29, 2016 Filed Jan 4, 2017 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | GiftCommon Stock | 182 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001309 · doc4.xml · nonDerivative · entry 1 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,848 F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 17:57 UTC | NUVASIVE INC NUVA · Entity 110002 | SaleCommon Stock | 10,303 | $67.99 | $700,500.97 |
DisclosureSEC source: 0001209191-16-155239 · doc4.xml · nonDerivative · entry 1 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,030 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · price: Weighted average sales price from sales transactions ranging from $67.63 to $68.35. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:59 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144595 · doc4.xml · derivative · entry 3 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on October 8, 2012. In accordance with the terms of the RSU award, the award vested as to 1,250 shares on each of October 1, 2013, October 1, 2014, October 1, 2015 and October 1, 2016. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on October 8, 2012. In accordance with the terms of the RSU award, the award vested as to 1,250 shares on each of October 1, 2013, October 1, 2014, October 1, 2015 and October 1, 2016. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:59 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 652 | $66.66 | $43,462.32 |
DisclosureSEC source: 0001209191-16-144595 · doc4.xml · nonDerivative · entry 2 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,333 F2 · shares: Payment of tax liability by Issuer's withholding of shares incident to the respective settlement of vested shares. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Amount includes 505 shares acquired under the Issuer's employee stock purchase plan in April 2016. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:59 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144595 · doc4.xml · nonDerivative · entry 1 Link Matthew · CIK 0001565950 · President, U.S. Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards. Amount includes 505 shares acquired under the Issuer's employee stock purchase plan in April 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.